Concerns on new diabetes medicine

Worries are raised about the safety of a new diabetes medicine Januvia (sitagliptin phosphate), a drug expected to be big sellers for MSD Korea. But it is unclear if the concerns are justified or just the result of a hair-trigger tendency concerning drug safety on the part of doctors.

In a press interview on October 11, Prof. Kim Kang-won of Samsung Medical Center said that Januvia may be a...